Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy(vol14, 1189058, 2023)

被引:0
|
作者
Yi, Jia-Qin [1 ]
Huang, Sheng [1 ]
Wu, Miao-Juan [1 ]
Ma, Jie-Hui [1 ]
Huang, Li-Juan [1 ]
Liang, Song [2 ]
Sun, Dan [1 ]
机构
[1] Huazhong Univ Sci & Technol, Wuhan Childrens Hosp, Tongji Med Coll, Dept Neurol, Wuhan, Peoples R China
[2] Hubei Third Peoples Hosp, Dept Pediat Rehabil, Wuhan, Peoples R China
关键词
perampanel; oxcarbazepine; newly diagnosed focal epilepsy; monotherapy; anti-seizure medications;
D O I
10.3389/fphar.2023.1295784
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页数:2
相关论文
共 36 条
  • [1] Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
    Yi, Jia-Qin
    Huang, Sheng
    Wu, Miao-Juan
    Ma, Jie-Hui
    Huang, Li-Juan
    Liang, Song
    Sun, Dan
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [2] Effectiveness and tolerability of perampanel monotherapy in children with newly diagnosed focal epilepsy
    Zhao, Fen
    Ren, Ying
    Geng, Guifu
    Zhang, Tong
    Hu, Wandong
    Zhang, Huan
    Jin, Ruifeng
    Shi, Jianguo
    Gao, Zaifen
    Zhang, Hongwei
    Liu, Yong
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [3] Topiramate monotherapy in newly diagnosed epilepsy, in children and adolescents
    Glauser, Tracy A.
    Dlugos, Dennis J.
    Dodson, W. Edwin
    Grinspan, Augusto
    Wang, Steven
    Wu, Shu-Chen
    JOURNAL OF CHILD NEUROLOGY, 2007, 22 (06) : 693 - 699
  • [4] Epileptiform activity index changes for prediction of Oxcarbazepine monotherapy efficacy in adults and adolescents with newly-diagnosed focal epilepsy
    Pushkar, Tatiana
    Azhigova, Asya
    Kozhokaru, Anzhela
    Vlasov, Pavel
    EPILEPSIA, 2021, 62 : 46 - 47
  • [5] Sustained effectiveness of long-term oxcarbazepine monotherapy in patients with newly diagnosed epilepsy
    Ben-Menachem, E
    Qian, C
    Sturm, Y
    EPILEPSIA, 2004, 45 : 138 - 138
  • [6] Comparative effectiveness of levetiracetam and oxcarbazepine as first drug monotherapy in children with focal epilepsy
    Chang, G.
    Wilson, J.
    Massey, S.
    Piccoli, C.
    Worden, L.
    Kessler, S.
    ANNALS OF NEUROLOGY, 2023, 94 : S56 - S56
  • [7] Evidence for sustained effectiveness of up to 4 years oxcarbazepine monotherapy for patients with newly diagnosed epilepsy
    Sturm, Y
    Qian, C
    Ben-Menachem, E
    EPILEPSIA, 2004, 45 : 129 - 129
  • [8] Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta-analysis
    Kharel, Sanjeev
    Ojha, Rajeev
    Khanal, Surendra
    BRAIN AND BEHAVIOR, 2022, 12 (11):
  • [9] Effectiveness and Safety of Oxcarbazepine vs. Levetiracetam as Monotherapy for Infantile Focal Epilepsy: A Longitudinal Cohort Study
    Zhao, Binyang
    Liao, Shuang
    Zhong, Xuefei
    Luo, Yuanyuan
    Hong, Siqi
    Cheng, Min
    Zhang, Jie
    Li, Tingsong
    Jiang, Li
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [10] Perampanel and lacosamide monotherapy in pediatric patients with newly diagnosed focal epilepsy: A prospective study evaluating efficacy, tolerability, and behavior
    Zhou, Rui
    Qu, Rui
    Liu, Min
    Huang, Dan-Ping
    Zhou, Jin-Yi
    Chen, Yan
    Chen, Xu-Qin
    EPILEPSY & BEHAVIOR, 2023, 146